Supplemented Low Protein Diet and Progression of CKD

NACompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

January 31, 2020

Study Completion Date

February 1, 2021

Conditions
Stage 4 Chronic Kidney Disease
Interventions
DIETARY_SUPPLEMENT

ketoanalogues of essential amino acids

Patients will receive conventional treatment according to the institution's clinical guidelines, with moderate restriction of proteins 0.6 g protein/kg/day, as recommended to slow renal damage progression), plus ketoanalogues in the established dosage (1 tablet/5 kg weight divided into 3 doses per day).

Trial Locations (2)

06722

Unidad de Investigación Médica en Enfermedades Nefrológicas, Instituto Mexicano del Seguro Social, Mexico City

06720

Unidad de Investigacion Medica en Enfermedades Nefrologicas, Hospital de Especialidades Centro Medico Nacional Siglo XXI, Mexico City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Fresenius Kabi

INDUSTRY

lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT03818568 - Supplemented Low Protein Diet and Progression of CKD | Biotech Hunter | Biotech Hunter